Search the Newsreel

The Manufacturers Life Insurance Company Sells 98,653 Shares of Annaly Capital Management Inc $NLY

The Manufacturers Life Insurance Company reduced its stake in Annaly Capital Management Inc. by 20.1% in the first quarter, selling 98,653 shares and retaining 392,128 shares valued at approximately $8.3 million. Despite this, institutional investors collectively own 51.56% of the company, and analysts generally …

Qualys drives up current billings 16% as it gains market share: analysts

Qualys reported a 16% year-over-year increase in current billings to $176.5M in its second quarter, marking its strongest growth in nearly three years. This surge, attributed to larger upsells and new product activity, has garnered positive feedback from financial analysts. The company's recent product …

Qualys, Inc. Stock 12‑Month Price Target Raised to $171.94, Implies 7% Upside

Analysts have raised the 12-month price target for Qualys, Inc. (QLYS) stock to an average of $171.94, up from $135.38, with a range of $125 to $220. This new target implies a potential upside of approximately 7% based on the August 4th closing price. …

Mineralys Therapeutics (MLYS) Gains 1.32% to $26.85 as Biotech Momentum Builds - Advance Decline Volume

Qualys (QLYS) Could Be 41% Overvalued Following Its Raised 2026 Guidance

Qualys (NASDAQ:QLYS) Hits New 12-Month High Following Strong Earnings

Qualys (QLYS) Stock Jumps 14% After Hours: Here's Why Qualys Shares Jump 14% After Hours on Strong Q2 Res

Qualys (QLYS) shares surged 14% in after-hours trading after reporting strong second-quarter results that surpassed analyst estimates. The company exceeded revenue forecasts, achieved a 46% adjusted EBITDA margin, and raised its full-year 2026 revenue and EPS guidance. Qualys also launched InstaScan, an AI-driven vulnerability …

Qualys Inc (QLYS) (Q2 2026) Earnings Call Highlights: AI-Driven Innovation and Raised Guidance ...

This article first appeared on GuruFocus. Revenue: $182.2 million, up 11% year-over-year. Adjusted EBITDA: $83.8 million, representing a 46% margin, up from 45% last year. EPS: $1.98 per diluted share for Q2 2026. Free Cash Flow: $55.9 million, representing a 31% margin. Operating Expenses: …

Joo Mi Kim Sells 1,627 Shares of Qualys (NASDAQ:QLYS) Stock

Qualys CFO Joo Mi Kim sold 1,627 shares of QLYS stock for approximately $249,000 as part of a pre-arranged trading plan, reducing her direct holdings to 75,743 shares. This transaction follows other recent sales by Kim, even as Qualys exceeded Q2 earnings and revenue …

Annaly (NYSE: NLY) CEO sells 50,000 shares in 10b5-1 trade

Annaly Capital Management CEO and Co-CIO David L. Finkelstein sold 50,000 shares of common stock on August 3, 2026, at a weighted average price of $22.89 per share. This sale was conducted under a Rule 10b5-1 plan established in November 2025 for tax and …

Health Catalyst, Inc. expected to post earnings of 3 cents a share - Earnings Preview

Health Catalyst, Inc. (HCAT) is projected to report earnings of 3 cents per share. This earnings preview, sourced from Refinitiv via Reuters, indicates the anticipated financial performance for the company. The full article provides further details on these expectations.

Qualys (NASDAQ:QLYS) Beats Q2 CY2026 Sales Expectations, Stock Soars

Qualys pops as Q2 results, guidance top estimates (QLYS:NASDAQ)

Qualys (QLYS) shares increased by 6.2% in extended trading after the cybersecurity firm announced second-quarter results and guidance that surpassed Wall Street's expectations. The company reported adjusted earnings of $1.98 per share for the period ending June 30. Revenue also saw a rise during …

Earnings Flash (QLYS) Qualys, Inc. Posts Q2 Adjusted EPS $1.98 per Share, vs. FactSet Est of $1.78

Qualys, Inc. (QLYS) reported Q2 adjusted EPS of $1.98 per share, surpassing FactSet's estimate of $1.78. The company also announced an increase in its Q2 revenue to $182.2 million, exceeding the FactSet estimate of $178.6 million. Following these results, Qualys, Inc. raised its earnings …

Qualys, Inc. (NASDAQ: QLYS) lifts 2026 guidance after 11% Q2 growth

Qualys Announces Second Quarter 2026 Financial Results

Q2 Revenue Growth of 11% Year-Over-Year Raises 2026 Revenue Guidance to $732.0-$738.0 million FOSTER CITY, Calif., Aug. 4, 2026 /PRNewswire/ -- Qualys, Inc. (NASDAQ: QLYS), a leading provider of disruptive cloud-based IT, security and compliance solutions, today announced financial results for the second quarter …

All eyes on Qualys earnings amid vulnerability management surge

Qualys Inc. is set to report second-quarter earnings, with investors keen to see if the rise in vulnerability disclosures translates into revenue growth and progress in its platform transition. Analysts anticipate $1.78 EPS on $178.63 million revenue, despite a neutral consensus rating and concerns …

Verisk Analytics Stock (VRSK) Opinions on Earnings and Acquisitions

This article discusses Verisk Analytics (VRSK) stock, focusing on social media opinions regarding its recent Q1 2026 earnings, which showed modest revenue and EPS growth, and its acquisition of McKenzie Intelligence Solutions. It also provides detailed breakdowns of insider trading activity, congressional stock trades, …

Why (CLST) Price Action Is Critical for Tactical Trading

This article provides an analysis of Catalyst Bancorp Inc. (NASDAQ: CLST) for tactical trading, highlighting a weak near-term sentiment but strong long-term outlook. It details specific trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with entry zones, targets, and stop losses. The analysis also includes …

Mineralys schedules live webcast for Aug. 11 Q2 update

Mineralys Therapeutics (Nasdaq: MLYS) announced it will report its second-quarter 2026 financial results after market close on Tuesday, August 11, 2026. The company will host a conference call and live webcast for investors and analysts at 4:30 p.m. ET on the same day to …

nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks Shares Are Soaring, What You Need To Know

Shares of nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks surged following easing geopolitical tensions and a new wave of AI-driven M&A activity. A diplomatic resolution regarding the Strait of Hormuz led to a drop in Treasury yields, benefiting growth-oriented tech equities. The …

Mineralys Therapeutics to Announce Second Quarter 2026

Mineralys Therapeutics, Inc. announced it will report its financial results for the second quarter ended June 30, 2026, after the financial markets close on Tuesday, August 11, 2026. The company will host a conference call on the same day at 4:30 p.m. ET to …

Qualys (NASDAQ: QLYS) grows Q2 2026 revenue and net income

Qualys (NASDAQ:QLYS) Issues Q3 2026 Earnings Guidance

Mineralys Therapeutics (MLYS) to Release Quarterly Earnings on Tuesday

Qualys, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:QLYS) 2026-08-04

Qualys, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management attributes …

Qualys (NASDAQ:QLYS) Posts Earnings Results, Beats Expectations By $0.20 EPS

Qualys (QLYS) Tops Q2 Earnings and Revenue Estimates

Annaly Capital Management, Inc. Announces Dates of First Quarter 2026 Financial Results and Conference Call

Annaly Capital Management, Inc. (NYSE: NLY) announced it will release its first-quarter 2026 financial results on Tuesday, April 21, 2026, after market close. The company will host a conference call and audio webcast to discuss the results on Wednesday, April 22, 2026, at 9:00 …

The Manufacturers Life Insurance Company Sells 8,441 Shares of Verisk Analytics, Inc. $VRSK

The Manufacturers Life Insurance Company reduced its stake in Verisk Analytics (NASDAQ:VRSK) by 10.3% in Q1 2026, selling 8,441 shares and retaining 73,192 shares worth $13.9 million. Despite this reduction, institutional investors collectively own approximately 90% of VRSK, and analysts maintain a "Moderate Buy" …

Affiliate of QLYS (QLYS) plans $384,600 sale of 2,657 common shares

An affiliate of Qualys, Inc. (QLYS) plans to sell 2,657 common shares with an aggregate market value of $384,600.75 on or after August 3, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. These shares are related to Restricted Stock Units …

Kalyani Investment Company Limited announces Annual dividend, payable on September 25, 2026

Teladoc Health adds former Verisk Analytics exec to board By Investing.com

Teladoc Health has appointed Mark V. Anquillare, former president and COO of Verisk Analytics, to its board of directors. Anquillare brings over 30 years of financial and executive leadership experience, including guiding companies through growth and transformation and overseeing an IPO. He will serve …

Verisk Analytics (NASDAQ: VRSK) ends Nicholas Daffan CIO role

Verisk Analytics (NASDAQ: VRSK) has announced that Nicholas Daffan no longer serves as Executive Vice President and Chief Information Officer, effective August 3, 2026. Consequently, he has also ceased to be a Section 16 officer of the company. The report indicates no insider share …

Verisk Analytics (VRSK) insider plans $696K stock sale after option exercise

An insider at Verisk Analytics (VRSK) has filed a Form 144 to sell 3,535 shares of common stock, valued at approximately $696,182.90. This planned sale, set for August 3, 2026, is connected to the exercise of employee stock options and will be executed as …

Verisk Analytics Insider Sold Shares Worth $696,183, According to a Recent SEC Filing

An insider at Verisk Analytics (VRSK) sold shares valued at $696,183, as disclosed in a recent SEC filing. The article highlights this insider transaction and also lists several recent analyst adjustments to price targets for Verisk Analytics, along with other company news such as …